Novo Nordisk announced that the prices of popular weight loss drugs Ozempic and Wegovy will significantly decrease starting in 2027, with Wegovy becoming half as expensive and Ozempic a third less expensive for all patients.
The Danish pharmaceutical giant Novo Nordisk has made a significant announcement regarding the pricing of its popular weight-loss medications, Ozempic and Wegovy. Starting in 2027, the prices for these drugs are set to drop dramatically, with Wegovy expected to be reduced by half and Ozempic by one third. This pricing move is significant given the growing demand for these medications and their popularity in weight management.
